PhRMA-backed Conservative Think Tank Suggests DOGE Should Prioritize 340B Reform to Cut Government Costs

ALEC, a drug industry-funded conservative policy group, suggested 340B reform “is a great place to start” in improving government efficiency.
A drug industry-funded conservative policy group suggested that 340B reform “should be a priority” for large scale government cost-cutting efforts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Hospital Sues HRSA Over 340B Removal, Seeks Retroactive Eligibility

A California-based hospital sued HRSA in the U.S. District Court for the District of Columbia, alleging the agency "unlawfully" prevented the hospital from accessing the 340B program for six months.
A California-based hospital has sued the Health Resources and Services Administration (HRSA), alleging the agency unlawfully prevented it from accessing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Connecticut Lawmaker Introduces 340B Cost Reporting Bill, Providers Warn of ‘Unnecessary Burden’

A Connecticut lawmaker introduced a bill this week that would require hospitals, pharmacies, PBMs and insurers to report how much they charge patients for 340B drugs.
Connecticut hospitals, pharmacy benefit managers (PBMs), pharmacies and insurance companies would have to report how much they charge patients for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NYT Investigation Highlights Federal Law’s Unintended Harm to 340B Providers

A recent New York Times investigation found that part of a COVID-19 relief bill meant to lower drug prices actually increased costs for 340B providers and some of their most vulnerable patients.
A provision in a 2021 COVID-19 relief bill that sought to lower prescription drug prices has actually made some medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Before Departing, Biden Admin Announces Next 15 Drugs for Medicare Negotiations Amid IRA Uncertainty and 340B Questions

The second group of high-cost prescription drugs chosen for Medicare price negotiations were announced last week just ahead of former President Joe Biden's departure from the White House.
The Department of Health and Human Services (HHS) announced the second group of high-cost prescription drugs chosen for Medicare price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House E&C Convenes Under New Leadership, Senate HELP Committee to Meet Next Week

The House E&C Committee convened for its first meeting of the 119th Congress on Jan. 15.
The House Energy and Commerce (E&C) Committee, which has jurisdiction over the 340B and Medicaid programs, held its first meeting [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

BMS Allows Additional Contract Pharmacy Designation for Cancer Drug; Vertex Adds Cystic Fibrosis Drug to Restrictions

Drugmakers Bristol Myers Squibb (BMS) and Vertex both issued changes to their contract pharmacy policies this month on 340B ESP’s website. 
Drugmakers Bristol Myers Squibb (BMS) and Vertex have each announced changes to their 340B contract pharmacy restrictions  that apply to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Program Had No Impact on Prostate Cancer Care, Study Suggests

A study in the academic journal Cancer Medicine examined the relationship between the 340B program and prostate cancer care.
Participation in the 340B program did not increase the number of vulnerable patients beginning targeted care for prostate cancer, a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Appeals in Mississippi and Maryland; Update in Missouri

Key briefs were filed over the past few weeks in litigation over state contract pharmacy access laws in Mississippi, Maryland and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Heron, Dr. Reddy’s, Organon, CooperSurgical Issue NDC Changes 

Four drugmakers have notified 340B covered entities of changes to certain national drug codes (NDC) for their products over the past three weeks.
Four drugmakers have notified 340B covered entities of changes to certain national drug codes (NDC) for their products over the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live